SCHEMBL23502248

SCHEMBL23502248

c1ccc2cc(-c3c4ccccc4c(-c4ccc5c(c4)c4ccccc4c4ccc6c7ccccc7oc6c45)c4ccccc34)ccc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 1/20 0.40
CYP1B1 Q16678 1/20 0.40
ALOX5 P09917 2/20 0.38
CYP1A2 P05177 2/20 0.37
NPC1 O15118 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
RAB9A P51151 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
AHR P35869 2/20 0.34
GPR84 Q9NQS5 1/20 0.33
HPGD P15428 3/20 0.33
CDC25A P30304 2/20 0.33
CDC25C P30307 2/20 0.33
KDM4E B2RXH2 2/20 0.33
MEN1 O00255 2/20 0.33
MAPT P10636 2/20 0.33
KMT2A Q03164 2/20 0.33
HSD17B10 Q99714 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23502220 1.00 CYP1A1 (0.40) CYP1A1CYP1B1ALOX5CYP1A2NPC1
SCHEMBL17944007 0.97 CYP1A1 (0.40) CYP1A1CYP1B1ALOX5CYP1A2NPC1
SCHEMBL23502193 0.94 ALOX5 (0.37) CYP1A1CYP1B1ALOX5CYP1A2NPC1
SCHEMBL17944695 0.94 CYP1A1 (0.38) CYP1A1CYP1B1ALOX5CYP1A2NPC1
SCHEMBL23502089 0.93 CYP1A1 (0.41) CYP1A1CYP1B1ALOX5CYP1A2NPC1
SCHEMBL17931951 0.92 CYP1A1 (0.37) CYP1A1CYP1B1ALOX5CYP1A2NPC1
SCHEMBL17931928 0.92 CYP1A1 (0.37) CYP1A1CYP1B1ALOX5CYP1A2NPC1
SCHEMBL16067763 0.92 CYP1A1 (0.39) CYP1A1CYP1B1ALOX5CYP1A2NPC1
SCHEMBL16067805 0.91 CYP1A1 (0.39) CYP1A1CYP1B1ALOX5CYP1A2NPC1
SCHEMBL17944436 0.90 PLA2G2A (0.39) CYP1A1CYP1B1ALOX5L3MBTL1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11038124-B2 Organic compound and organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2021-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11038124-B2 Organic compound and organic electroluminescence device using the same TRPA1, TRPC6, TRPM4 CYP1A1 926/4885CYP1B1 1660/4885ALOX5 923/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.